Neo Ivy Capital Management Takes Position in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Neo Ivy Capital Management purchased a new stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 12,516 shares of the semiconductor company’s stock, valued at approximately $1,312,000.

A number of other hedge funds and other institutional investors have also modified their holdings of ACLS. Boston Trust Walden Corp bought a new position in Axcelis Technologies in the 3rd quarter worth $53,099,000. Reinhart Partners LLC. raised its holdings in Axcelis Technologies by 64.1% in the 3rd quarter. Reinhart Partners LLC. now owns 687,608 shares of the semiconductor company’s stock worth $72,096,000 after acquiring an additional 268,560 shares during the period. Granite Investment Partners LLC bought a new position in Axcelis Technologies in the 2nd quarter worth $27,801,000. Royce & Associates LP raised its holdings in Axcelis Technologies by 157.1% in the 3rd quarter. Royce & Associates LP now owns 273,671 shares of the semiconductor company’s stock worth $28,694,000 after acquiring an additional 167,235 shares during the period. Finally, Weiss Asset Management LP bought a new position in Axcelis Technologies in the 3rd quarter worth $13,874,000. Institutional investors own 89.98% of the company’s stock.

Axcelis Technologies Stock Performance

NASDAQ ACLS opened at $76.49 on Wednesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.45 and a quick ratio of 3.29. The firm has a market capitalization of $2.49 billion, a price-to-earnings ratio of 11.32, a P/E/G ratio of 2.31 and a beta of 1.53. The company’s fifty day moving average is $85.48 and its two-hundred day moving average is $108.04. Axcelis Technologies, Inc. has a 52-week low of $69.35 and a 52-week high of $158.61.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Axcelis Technologies in a report on Friday, November 8th. Benchmark downgraded shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Axcelis Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $167.33.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.